Silva Mário J, Rosa Matilde V, Nogueira Paulo J, Calinas Filipe
aGastroenterology Department, Central Lisbon Hospital Centre bNOVA Medical School cDirectorate of Analysis and Information, Directorate-General of Health dInstitute for Preventive Medicine and Public Health, Faculty of Medicine, University of Lisbon, Portugal.
Eur J Gastroenterol Hepatol. 2015 Nov;27(11):1320-6. doi: 10.1097/MEG.0000000000000449.
More data on epidemiology of liver diseases in Europe are needed. We aimed to characterize hospital admissions for liver cirrhosis in Portugal during the past decade.
We analyzed all hospital admissions for cirrhosis in Portugal Mainland between 2003 and 2012 registered in the national Diagnosis-Related Group database. Cirrhosis was classified according to etiology considering alcohol, hepatitis B, and hepatitis C.
Between 2003 and 2012, there were 63,910 admissions for cirrhosis in Portugal Mainland; 74.4% involved male patients. Etiologies of admitted cirrhosis were as follows: 76.0% alcoholic, 1.1% hepatitis B, 1.4% hepatitis B plus alcohol, 3.6% hepatitis C, and 4.0% hepatitis C plus alcohol. There was a significant decline (P<0.001) in admissions for alcoholic cirrhosis, whereas hospitalizations for cirrhosis caused by hepatitis C or hepatitis C plus alcohol increased by almost 50% (P<0.001). Patients admitted with alcoholic plus hepatitis B or C cirrhosis were significantly younger than those with either alcoholic or viral cirrhosis (53.1 vs. 59.4 years, respectively, P<0.001). Hospitalization rates for cirrhosis were 124.4/100,000 in men and 32.6/100,000 in women. Hepatocellular carcinoma and fluid retention were more common in viral cirrhosis, whereas encephalopathy and variceal bleeding were more frequent in alcoholic cirrhosis. Hepatorenal syndrome was the strongest predictor of mortality among cirrhosis complications (odds ratio 12.97; 95% confidence interval 11.95-14.09). In-hospital mortality was 15.2%.
Despite the decline in admissions for alcoholic cirrhosis and the increase in those related to hepatitis C, the observed burden of hospitalized liver cirrhosis in Portugal was essentially attributable to alcoholic liver disease.
欧洲需要更多关于肝脏疾病流行病学的数据。我们旨在描述过去十年葡萄牙肝硬化患者的住院情况。
我们分析了2003年至2012年在葡萄牙大陆全国诊断相关组数据库中登记的所有肝硬化住院病例。根据病因将肝硬化分为酒精性、乙型肝炎和丙型肝炎。
2003年至2012年期间,葡萄牙大陆有63910例肝硬化住院病例;74.4%为男性患者。肝硬化的病因如下:酒精性76.0%,乙型肝炎1.1%,乙型肝炎合并酒精1.4%,丙型肝炎3.6%,丙型肝炎合并酒精4.0%。酒精性肝硬化的住院病例显著下降(P<0.001),而丙型肝炎或丙型肝炎合并酒精导致的肝硬化住院病例增加了近50%(P<0.001)。酒精性合并乙型或丙型肝炎肝硬化患者比酒精性或病毒性肝硬化患者明显年轻(分别为53.1岁和59.4岁,P<0.001)。肝硬化的住院率男性为124.4/10万,女性为32.6/10万。肝细胞癌和腹水在病毒性肝硬化中更常见,而肝性脑病和静脉曲张出血在酒精性肝硬化中更频繁。肝肾综合征是肝硬化并发症中最强的死亡预测因素(比值比12.97;95%置信区间11.95-14.09)。住院死亡率为15.2%。
尽管酒精性肝硬化住院病例有所下降,丙型肝炎相关病例有所增加,但葡萄牙观察到的肝硬化住院负担基本上归因于酒精性肝病。